Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Case-mix adjusted 30-day mortality after receiving SACT in England, 2017-2019

This tool presents the number and case-mix adjusted 30-day mortality rate (percentages) of patients in England following treatment with systemic anti-cancer therapy (SACT) in 2017-2019. The 30-day post SACT mortality rates have been adjusted for variations in patient case mix, allowing for comparisons to be made across trusts, or within a trust over time.